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Inhaler and Nebuliser Technique for 
Individuals with a Learning Disability 
 
Samuel J Clark and Jillian Pawlyn Jillian.Pawlyn@open.ac.uk  
 
Abstract 
Health carers providing support to individuals requiring an inhaler or nebuliser need to 
know how to use, monitor and assess inhaler technique effectively.  
Many individuals requiring an inhaler will often have poor technique which results in an 
insufficient amount of medication being inhaled into the lungs, consequently the 
medication having less impact on treating the condition it is prescribed for. In order to 
ensure individuals, have adequate inhaler technique, their performance needs to be 
reviewed and monitored by an appropriately trained health care professional to ensure its 
effectiveness.  
Poor inhaler technique can lead to poor management of their respiratory condition, 
increasing symptoms, reducing quality of life, increasing the need to use primary/secondary 
care services and growing the cost to treat the disease.  
This article will demonstrate how to use an inhaler and nebuliser successfully and consider 
some of the challenges this skill can have with individuals with a Learning Disability (LD) due 
to their cognitive impairment and pre-existing conditions. It will also identify some of the 
other different devices and assessment tools available. It will explore assessment/review 
methods to help ensure the individual is taking the inhaler/nebuliser successfully. 
Keywords 
Learning Disability, Intellectual Disability, Inhaler, Technique, Nebuliser, Clinical Skill, 
Respiratory Conditions, Self-Management, Assessment, Nurse,   
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Aim and intended learning outcomes 
The aim of this article is to demonstrate how to use an inhaler and nebuliser effectively and safety, 
with a specific focus on individuals with a Learning Disability (LD). Supporting the Nursing and 
Midwifery Council (NMC) The Code especially in relation to point 18 “Advise on, prescribe, supply, 
dispense or administer medicines within the limits of your training and competence” (p 5 NMC 2015). 
 
After reading this article the reader will be able to: 
• Administer an inhaler and nebulisers effectively; 
• Recognise that different inhalers require different techniques to administer 
effectively; 
• Assess that an individual has administered an inhaler or nebuliser successfully; 
• Promote self-administration of inhalers in individuals with LD 
• Contemplate some of the adjustments required for an individual with LD; 
• Use inhaler assessment tools to assess if an individual is using the inhaler correctly; 
• Ponder a change of inhaler type or additional equipment to help ensure 
optimisation of the medication; 
• Consider if an individual with a LD requires closer monitoring to promote self-
management; 
Introduction 
Heslop et al (2013) ‘Confidential Inquiry into the Deaths of People with Learning Disability 
(CIPOLD)’ recommended that adults with LD to be considered a high-risk group for deaths 
from respiratory problems. Having the insight of the additional challenges these health 
problems present for individuals with a LD who are already a known to be a high-risk group 
experiencing co-morbidities arising from long–term conditions (Public Health England (PHE) 
2016) is of paramount importance for the health carer. In achieving a therapeutic goal 
promoting self-care and independence (Aldridge 2010) it is important to involve the 
individual with LD in the choice of inhaler and select a device they find easy to use (Davis, 
2016). ‘Reasonable adjustments’ (Equality Act 2010; PHE 2017) should be anticipated, the 
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individual with a LD may require additional support and guidance to select their device and 
develop an effective technique; ‘Patient friendly’ monitoring can help manage symptoms 
(Stothard, 2017). The individual is likely to benefit from familiarisation/desensitisation to 
the equipment and procedures, preparation is likely to reduce the individual’s anxiety or 
fear and increase positive outcomes for all involved. 
Inhalers are one the most common medication prescribed in the United Kingdom (UK), the 
Prescription Cost Analysis (NHS Digital 2017) states that over £1 billion is spent on the 
respiratory system medication alone, with inhalers making the largest percentage of money 
spent on this system. Beclometasone dipropionate (a corticosteroid inhaler) accounting for 
the most amount of money the National Health Service (NHS) England spends on a single 
drug, costing over £174 Million a year (NHS Digital 2017). Two of the most common diseases 
that require inhalers and nebulisers for treatment include asthma and Chronic Obstructive 
Pulmonary Disease (COPD). Currently around 5.4 million people are receiving treatment for 
asthma in the UK (Asthma UK 2018) and an estimated 1.2 million are diagnosed with COPD 
in the UK British Lung Foundation (BLS) (2018). A significant percentage of people with 
asthma and COPD will also have a LD as Mencap (2013) reports that 1.5 million people have 
a LD within the UK, an estimated 2% of the UK population.  
A report by Allan et al (2012) highlights individuals with LD who smoke are twice as likely to 
have asthma and more than half of women with LD and asthma also have associated 
problems with obesity (a risk factor for poorly controlled asthma).  The report (Allan et al 
2012) also indicates that respiratory disease is the leading cause of death for people with LD 
and is responsible for around half of all deaths among people with LD this is much higher 
than for the general population diagnosed with respiratory disease.  
It has been highly reported that people with LD experience significant health inequalities 
compared to the general population, with higher levels of unmet needs PHE (2016) delays in 
access to diagnosis, investigations or specialist referrals (Mencap 2007, 2012) resulting in a 
higher incidence of untimely deaths (Mencap 2012; Heslop et.al 2013; PHE 2016). 
 
According to Price et.al. (2013) despite the high cost of inhalers, the frequency of 
prescription review, and opportunity for patient education on inhaler use, many individuals 
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still have poor inhaler technique. Global Initiative for Asthma (GINA) (2018) highlights that 
between 70-80% of people with asthma are unable to use their inhaler correctly with similar 
figures reported in those with COPD. Poor inhaler technique leads to poor disease control, 
reduced quality of life (QoL), increased emergency admissions and higher treatment cost 
(AL-Jahdali et al. 2013; Stothard 2017).   Worryingly research has also suggested that many 
health care staff have poor assessment technique when teaching/assessing patient’s inhaler 
technique and unable to perform or talk through the critical steps of using an inhaler (Fink & 
Rubin 2005). As a heath carer, supporting individuals with LD it is essential to know how to 
administer an inhaler and nebuliser effectively. Being able to deliver, assess and monitor 
inhaler technique effectively, suggesting additional equipment/inhaler type, and being 
present during outpatient appointments could all help to ensure the medication is delivered 
effectively thus improving symptoms and QoL (Global Initiative for Chronic Lung Disease 
(GOLD) 2018; GINA 2018).  
 
Time out 1 
Review the National Institute for Health and Care Excellence (NICE) (2017) Asthma: 
diagnosis, monitoring and chronic asthma management [online] 
https://www.nice.org.uk/guidance/ng80 
Are you implementing this guidance in your own practice? List three improvements that 
could be made to your practice as a result of reading this guidance. Consider how you could 
disseminate this information to your colleagues. 
Depending on the clinical need of the LD individual, you may also wish to review a different 
clinical guideline https://www.nice.org.uk/guidance/conditions-and-diseases/respiratory-
conditions 
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Inhaler  
They are many different inhalers available; the two main types of inhalers are Metered Dose 
Inhalers (MDI) and Dry Powder Inhalers (DPI). Within these two types of inhalers, there are 
various brands and versions depending on the manufacture, drug and pharmaceutical 
company.  MDI and DPI each require a slightly different inhaler technique in order to 
administer the medication affectively. It is worth remembering that certain drugs may only 
be available in MDI or DPI form British National Formulary (BNF) (Joint Formulary 
Committee, 2018).  
Metered Dose Inhalers (MDI) 
MDI are the most common type of inhaler (Image A) used in practice and often the cheapest 
method of delivering the medication (Joint Formulary Committee, 2018). MDI dispense 
medication through an aerosol spray or mist, through each push of a canister a measured 
dose of medication is produced (Perry, Potter & Elkin 2012).  This type of inhaler requires a 
degree of dexterity as the individual needs to be able to inhale at the same time the 
medication is being delivered (canister is pushed) (Lynes 2007). The individual needs to 
ensure that they are inhaling slowly and deeply to ensure that the drug goes to the 
peripheral airways instead of the mouth or throat (Capstick & Clifton 2012). They also need 
to understand the importance of following this process correctly in order to optimise the 
medication delivery. Inhalers need to be cleaned regularly following the manufactures 
instructions. 
Image A  
Example of MDI  
 
 
Time out 2 
Please watch this short video on how to take a MDI, this will help to reinforce the 
information you have read. Asthma UK (2012) How to take a Metered Dose Inhaler 
https://youtu.be/FqztOZLqFhE 
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As you view the video consider how you would explain and demonstrate this technique to 
an individual with LD. 
Identify any reasonable adjustments which may be required (see Box 1).  
Identify the role of the family carer, how this might differ from that of a paid carer? 
 
Breath-Actuated Inhaler (BAI)  
Breath-Actuated Inhaler (BAI) see (Image B) is a different form of the MDI. The medication 
comes in an aerosol canister however this is not visible, and the individual cannot push the 
canister down. When the patient inhalers a mechanism automatically realises the drug, this 
means inhalation and actuation coincide with each other (Currie 2011). This is useful as the 
dexterity is not as essential, as with the MDI, however the individual still needs to focus on 
the strength of inhalation to ensure it reaches the lungs adequately (Newman et al. 1991). 
BAI have been demonstrated to improve the deposition of aerosol within the lungs for 
patients who have difficulty coordinating Inhalation when previously using MDI (Capstick & 
Clifton 2012). A slow and steady inhalation is still required to ensure optimisation of 
medication. 
It may be worth considering swapping to this form of inhaler if the individual is finding the 
MDI challenging. 
This form of inhaler is much more expensive than the MDI (Joint Formulary Committee, 
2018). 
Image B  
An example of a BAI inhaler  
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Time out 3 
Please watch these two short videos on how to take two different types of BDI, to help 
reinforce the information you have read. 
Asthma UK (2012) How to take an Easi-Breathe inhaler  - https://youtu.be/Qf-yHFEq8lU 
Asthma UK (2012) How to take an Autohaler - https://youtu.be/5q7FpntKnm8 
As you view these videos consider how you would explain and demonstrate these 
techniques to an individual with LD.  
Dry Powder Inhalers (DPI) 
DPI (Images C, D, E, F,) medication comes in a dry powder different to that of the MDI. The 
main advantage of DPI is that they do not require coordinated activation (Bonni & Usmani 
2015). Therefore, use is similar to that of the BAI. The mechanism of the inhaler works 
differently to the BAI.  
 
The major differences to that of the MDI are that in order for this type of inhaler to work 
effectively, the medication needs to be inhaled quickly and deeply and the medication 
needs to be made active by the individual in order for it to be delivered.  DPI requires much 
higher inhalation flows than MDI, and not using a forceful and deep inspiration is a common 
critical issue with DPI (Bonni & Usmani 2015). Depending on the type of DPI activating the 
medication may involve twisting, clicking or manually adding the medication to the inhaler. 
The variation in techniques may cause some additional confusion to the individual with a LD 
(especially if using different types of DPI & MDI).  The medication is drawn out of the blister 
or capsule by the user’s inhalation, so individuals will need to be able to take a quick and 
deep breath in to pull the medication out of the carrier (Scullion 2017). 
 
For this type of inhaler, the medication is often more expensive compared to the MDI (Joint 
Formulary Committee, 2018). 
Image C  
Single dose of DPI inhaler (example) 
 
Clark and Pawlyn    - 8 -   17th September 2018 
Image D, E, F, 
Multi-dose DPI inhalers (example) 
Time out 4 
Please watch these two short videos on how to take two different types of DPI. This will to 
help reinforce the information you have read. 
Asthma UK (2012) How to take an Accuhaler inhaler https://youtu.be/0mgggfL0zjw 
Asthma UK (2012) How to take an Turbohaler inhaler https://youtu.be/2_6DvPwZj2s 
As you view these videos consider how you would explain and demonstrate these 
techniques to an individual with LD.  
Revisit ‘Time out 2’  
Additional Equipment 
Additional equipment can be attached to inhalers to help improve technique and efficacy, 
for instance a lever can be added for individuals who struggle to push the aerosol down 
(MDI). These are often added for individuals who have a physical condition such as 
rheumatoid arthritis.  
Additional assessment devices are also available that can help ascertain if the individual is 
inhaling too softly or too strongly; this equipment can be useful to help promote the correct 
strength of inhalation for the individual using a MDI. Placebo inhalers are also available to 
help assess and improve technique and can be useful when training and assessing (Image 
G); a lack of placebo inhalers in clinical practice is often a barrier to provide adequate 
inhaler technique training GOLD (2018).  
 
Image G 
Placebo MDI inhaler  
Spacers can also be added if an individual has poor coordination when using a MDI inhaler. 
As part of the assessment process it is necessary to understand and utilise these additional 
equipment pieces as it will help to improve optimisation of the medication.  
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Spacers 
Spacers (Images H, I, J, K,) are useful if an individual has poor dexterity or difficulty with the 
coordination when using a MDI. A spacer may be a useful additional equipment piece and is 
often used with children, the elderly and people with physical disability or LD (Sanchis et.al 
2016).  
 
The medication is delivered into a valued chamber acting as a temporary reservoir before 
inhalation this helps to slow the delivery of the medication (White 2015). The medication is 
delivered into the spacer and the individual does not need to focus on inhalation at the 
same time as the canister being pushed, thus reducing the coordination required. There are 
also two different breathing techniques (single breath or multiple breaths) that can be used 
with a spacer however this still requires a slow and steady inhalation; the individual may 
find one breathing technique easier than the other. Certain brands of spacer will whistle if 
the inhalation is too quick, this audible reference may be useful when promoting successful 
inhaler technique. A mask is sometimes added to the spacer if the individual lacks the 
coordination to make a seal around the inhaler mouthpiece. This is often used with young 
children and again maybe suitable to consider with individuals with LD. Spacers need to be 
cleaned regularly according to the manufactories recommendation.   
Image H, I, J, K.  
Types of spacers. 
Volumatic 
AeroChamber Plus 
Able Spacer 
Antistatic holding chamber 
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Time out 5 
Please watch these short videos on how to use a spacer including different breathing 
techniques and using them on children, to help reinforce the information you have read. 
Asthma UK (2012) How to use a Small Volume Spacer  https://youtu.be/fZPS_w54rfY 
Asthma UK (2012) How to use a Large Volume Spacer (single breath technique) 
https://youtu.be/5-HT9mt8GG0 
Asthma UK (2012) How to use a Large Volume Spacer (multiple breath technique)  
https://youtu.be/yYscA7XkfTc 
Asthma UK (2014) How to use a Small Volume Spacer with a child 
https://youtu.be/RKj9SzU6SV4 
Asthma UK (2014) How to use a Large Volume Spacer with a child 
https://youtu.be/1ERSL2UyCN0 
Asthma UK (2014)How to use a Large Volume Spacer (with a mask for a child)  
https://youtu.be/SIbYtZJ3U7U 
Nebuliser 
Nebulisers can be used through a compressor (Image L), an ultra-sonic or through piped O2 
or air (often only available in secondary care). Nebulisers use oxygen, compressed air or 
ultrasonic power to break up medical solutions into fine aerosol mist that can be directly 
inhaled from the mouthpiece/mask Curie (2011).  A nebuliser normally takes around 5-10 
minutes (British Thoracic Society (BTS) 1997; NICE 2018) however it can be challenging to 
determine when to stop the nebuliser. Informing the user that nebulisation therapy usually 
continues until the volume left in the nebuliser is so low that the nebuliser ceases to 
function continuously and begins to "splutter" (Boe et al 2001) this is the sign to turn the 
nebuliser off. Often used in more acute settings, nebulisers often use the same drug as an 
inhaler but at larger dosages, if an Individuals unable to coordinate an inhaler effectively 
and medication that is required that is only available via this route i.e. nebulised antibiotics 
(Blackler, Jones & Mooney, 2007).   
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If an individual does not have the dexterity to take an inhaler a nebuliser may be the only 
option available. However, currently there is no evidence that shows nebuliser therapy is 
superior to inhalers if inhalers are used correctly (GOLD 2018). According to Davis (2016), 
nebulisers should be prescribed to individuals with LD with social/visual attentiveness 
deficits or for whom inhalers have proved unsuccessful. However their previous study (Davis 
et al 2015) found that paid care givers didn’t believe they have had appropriate training in 
the use of nebulisers. It is therefore imperative that carers are provided with appropriate 
training and support individuals in the correct usage of their nebuliser.  
Nebulisers can be delivered though a mouthpiece or face-mask (Image M & N). Face masks 
are used more frequently used in secondary care if the patient is acutely ill as it is more 
likely to ensure the patient receives the medication. 
According to Kelly and Lynes (2011) research has shown that the nebuliser equipment is 
often not cleaned correctly after use resulting in bacteria growing within them. This will put 
the patient at direct risk of respiratory infections as the contaminated vapour will be 
breathed directly into the lungs. Therefore, cleaning the equipment adequately after use is 
an essential part of the process. This process involves cleaning with warm soapy water and 
being left to air dry, and it should be performed at least daily if the nebulisers are used 
regularly (Kelly and Lynes 2011) Nebulisers also require to be serviced regally to ensure their 
effectiveness. 
 
Image L    
Air Compressor     
                    
Image M    
Nebuliser face mask     
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Image N  
Nebuliser mouthpiece 
 
Time out 6 
Please watch this short video on how to take a use a nebuliser, to help reinforce the 
information you have read. It also contains an inhaler and spacer consultation for your 
reference. The second video demonstrates how to clean your nebuliser. 
Oxford Medical Education (2012) Inhaler and Nebuliser Explanation 
https://youtu.be/hjdIyyC8T-E  
How to Clean a Nebulizer American Lung Association (2015) How to Clean a Nebulizer 
youtube.com/watch?v=HFT4v7EhLUw 
As you view the videos consider how you would explain and demonstrate the techniques to 
an individual with LD.  
Identify any reasonable adjustments which may be required (see Box 1). 
Identify the role of the family carer, how this might differ from that of a paid carer? 
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Inhaler technique 
Below is a basic 7 steps technique checklist (Table 1). This is relevant to all inhalers types. 
This is a simple and easy checklist to follow when teaching/assessing inhaler technique and 
can be used for both MDI & DPI. However, the type of inhalation is different depending on 
whether the inhaler is a MDI or DPI. 
 
Table 1: Inhaler Technique checklist 
Inhaler technique checklist 
1. Prepare the device (e.g. remove the mouthpiece cover, open the device, hold the 
inhaler upright) 
2. Prepare the dose (e.g. shake all aerosols and load dose for DPIs) 
3. Breathe out gently as far as is comfortable (not into inhalers) 
4. Put the mouthpiece in the mouth and close the lips around it 
5. Breathe in: 
Check co-ordination of breathing and actuation of MDI 
Think about the type of inhaler device - is it an aerosol device or DPI? 
Breathe in slowly and steadily for all aerosol devices (including through a spacer device). 
Breathe in quickly and deeply for all DPIs 
6. Remove inhaler from the mouth and hold breath for ten seconds 
7. Repeat dose (if applicable), replace mouthpiece cover or close device. (Murphy 2016, 
p.9)  
 
Annual Reviews 
In order to determine if an inhaler/nebuliser is being taken effectively it is essential that this 
is reviewed and monitored correctly. This assessment/review is usually undertaken by a 
practice nurse during a yearly review of the condition for example within an Asthma/COPD 
clinic and forms part of the individuals ‘Annual Health Check’ (NHS England, 2017; Royal 
College of General Practitioners (RCGP) n.d.). NICE (2013) quality standard stipulates that an 
individual with asthma receives a structured review each year. However, despite yearly 
assessment the individual often reverts back to poor inhaler technique within a short period 
of time (Price et.al. 2013). This poor practice is likely to be more prevalent with individuals 
with a LD where retention of information regarding technique and dexterity in the skills is 
compromised. To assist with support and continuity of care it is imperative that the 
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intervention is clearly and accurately recorded in the individual’s health action plan (RCGP 
n.d.). The nurse can help to promote adequate inhaler technique, and this is a vital part of 
the yearly review. Please see the table below (Table 2) for some common inhaler errors to 
be aware of. 
 
Table 2: Common inhaler technique errors 
Common inhaler technique errors 
Failure to co-ordinate actuation and inhalation  
Inadequate or no breath hold after inhalation  
Too rapid inspiration / not inhaling forcibly  
Inadequate shaking / mixing before use  
Cold Freon effect (the initial reaction to the cold blast of MDI aerosol on the back of the 
throat can result in the patient aborting the inhalation process) 
Actuation at total lung capacity / Not exhaling to residual volume before inhaling 
Multiple actuations during single inspiration  
Inhaling through nose during actuation  
Exhaling during activation / through the mouth piece  
Putting wrong end of inhaler in mouth  
Holding device in wrong position / incorrectly 
Exhaling into the mouth piece after inhalation    (Chrystyn & Price, 2009) 
 
According to Stothard (2017) study an asthma outpatient department acknowledged the 
additional challenges individuals with LD face and increased the outpatient visit from 10 
minutes to 30 minutes focusing on a tailored education management programme and 
adherence to treatment. Over a 10-month period of this new intervention being 
implemented accessed emergency care services dropped by 25% (Stothard 2017); their 
intervention demonstrates clear benefits and highlights that individuals with LD may require 
additional time and support to promote self-management. 
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Time out 7 
Read the article by Price et al (2013) Inhaler competence in asthma: Common errors, 
barriers to use and recommended solutions. Respiratory Medicine. 107 (1) 37-46.  
While viewing ‘Table 1’ in the article, identify the critical errors and adjustments which may 
be required when supporting a person with LD. 
Please use the link below as an example of an inhaler checklist that is being used in clinical 
practice. 
NHS Liverpool Clinical Commissioning Group (2013) Inhaler Technique Checklist  
http://psnc.org.uk/liverpool-lpc/wp-content/uploads/sites/117/2016/06/Inhaler_Technique_Checklist.pdf 
Could you use this or something similar when assessing the inhaler technique of individuals 
with LD? 
What do you use to review nebuliser technique? 
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Case Study 
Jim attends your asthma clinic today, this is the first time he has attended the asthma clinic. 
Jim has had a recent hospital admission for pneumonia and was treated with intravenous 
antibiotics. During this admission Jim was diagnosed with asthma and was prescribed MDI 
inhalers. Jim has made a full recovery following acquiring pneumonia; on discharge the 
medical staff have indicated that Jim requires a regular review of his asthma and have 
referred this to the primary care team. 
Jim is a 28-year man with a moderate level of learning disability and autism, he requires 
support to maintain his activities of daily living (ADL).  Jim lives with two friends, who both 
have LD. Jim and his friends employ a small team of carers to support them. One of Jim’s 
carers attends the clinic with Jim. Jim is unsure about his asthma and struggles to describe 
his symptoms. The carer states Jim appears to get short of breath on exertion and his 
symptoms appear worse during the summer months.  
He has no other past medical history and does not smoke or drink alcohol. You assess his 
inhaler technique and Jim is unable to use his MDI effectively despite promoting and 
appears confused as to what his inhalers are intended for. 
 
Answer the following from this case study: (You may find it beneficial to review some of the 
resources and your responses during your time out activities). 
1. How would you assess Jim inhaler technique? 
2. How would you teach Jim accurate inhaler technique? 
3. What inhaler and additional equipment do you feel could improve Jim’s inhaler 
technique? 
4. How would you review Jim regarding his inhaler technique?  
5. What advice would you offer Jim and his care team? 
6. What factors would contribute towards Jim being more at risk of not managing his 
asthma effectively? 
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Conclusion 
Individuals with LD experience significant health inequalities compared to the general 
population with higher levels of unmet needs and delays in access to diagnosis, 
investigations or specialist referrals (Heslop et.al. 2013; PHE, 2016). With recent high-profile 
cases highlighting that individuals’ having a long-term condition alongside a LD the care is 
often substandard (Heslop et.al.2013; MENCAP 2013; PHE 2016). The need to ensure 
effective inhaler technique is paramount. It is essential as a nurse supporting an individual 
with a LD to have the knowledge and understanding of how inhalers are used, assessed and 
monitored correctly, coinciding with the NMC code. This will help to ensure optimisation of 
the medication thus helping to reduce clinical symptoms, improve QoL and reduce the need 
to attend primary and secondary care services (GINA  2108 & GOLD 2018).   
By reading and carrying out the tasks & case study in this article the reader will understand 
how to deliver an inhaler correctly for MDI, DPI and nebulisers. The reader will have insight 
into the additional challengers this skill requires for individuals with LD. The reader will be 
able to assess and monitor inhaler technique accordingly and consider when additional 
equipment or change of inhaler type might help improve optimisation of the medication.  
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Box 1 Reasonable adjustments   
  
Reasonable adjustments: 
 
Public Health England (2017) Reasonable adjustments: a legal duty (Guidance) [Online]  
Available from: https://www.gov.uk/government/publications/reasonable-adjustments-
for-people-with-learning-disabilities/reasonable-adjustments-a-legal-duty 
 
NHS England (no date)  Reasonable adjustments [Online].  Available from: 
https://www.england.nhs.uk/learning-disabilities/improving-health/reasonable-
adjustments/    
 
Asthma UK – Easy read resources - 
https://www.asthma.org.uk/advice/resources/#easyread  
Explore the resources in this site and review them for use in your own practice 
think about how you will share these resources with your colleagues.  
What ‘Easy Read’ resources do you have available for use in your practice area?  
What equipment will you require to demonstrate technique?  
Try using the term “easy read” to search for other online resources. 
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